PROLIXIN DECANOATE Drug Patent Profile
✉ Email this page to a colleague
When do Prolixin Decanoate patents expire, and what generic alternatives are available?
Prolixin Decanoate is a drug marketed by Bristol Myers Squibb and is included in one NDA.
The generic ingredient in PROLIXIN DECANOATE is fluphenazine decanoate. There are nineteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the fluphenazine decanoate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Prolixin Decanoate
A generic version of PROLIXIN DECANOATE was approved as fluphenazine decanoate by FRESENIUS KABI USA on July 14th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROLIXIN DECANOATE?
- What are the global sales for PROLIXIN DECANOATE?
- What is Average Wholesale Price for PROLIXIN DECANOATE?
Summary for PROLIXIN DECANOATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 57 |
| Patent Applications: | 1,965 |
| DailyMed Link: | PROLIXIN DECANOATE at DailyMed |
US Patents and Regulatory Information for PROLIXIN DECANOATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol Myers Squibb | PROLIXIN DECANOATE | fluphenazine decanoate | INJECTABLE;INJECTION | 016727-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
